Insights
Access our latest insights & resources
Sector: Healthcare
August PDUFA Calendar
Research, Policy
August will be a busy month for FDA approvals with unofficially 22 applications...
Read moreShockwave (SWAV): No Higher Rates For Now
Research, Policy
In omitting any narrative discussion of Shockwave’s (SWAV) coronary lithotripsy device..
Read moreFDA Action on Aspartame Unlikely
Research, Policy
Recent reports that the World Health Organization (WHO) will reclassify aspartame...
Read more[CVS, CI, UNH, ELV, HUM]: PBM Policy Noise and Concerns
Research, Policy
The House Education and Workforce Committee markup of four healthcare bills and the reported...
Read moreEuropean Health Care Equipment & Services: Receding Headwinds
Research, Fundamental
We see easing headwinds for the European Health Care Equipment & Services industry...
Read moreRevvity: Revitalized for Stronger Growth
Research, Fundamental
Rebranded as Revvity, it aims at becoming a high growth, high margin firm...
Read moreHealth Care REITs Poised for Healthy Returns
Video, Fundamental
The aging US population and increasing healthcare expenditures...
Read more[CVS, CI, UNH, ELV]: Entrenchment of PBM Overhang with More Bills Expected
Research, Policy
No relief for PBMs [CVS (CVS), Cigna (CI),...
Read moreMay 2023 PDUFA Calendar
Research, Policy
Delays in approvals due to disrupted work schedules at FDA because of the coronavirus...
Read moreSilk Road (SILK): Competition & Coverage
Research, Policy
Amid investor fears of competitive risks to Silk Road Medical’s (SILK)’s TCAR procedure...
Read more